Target Pharma & CRO leads at WPSC Americas 2026WPSC 美洲 2026 目标药企与 CRO leads
38 speaker leads from 32 organizations, derived from the public WPSC speaker roster. Tiers derived from seniority (T1 = C-suite / SVP, primary outreach).
32 家机构共 38 位 speaker leads,源自 WPSC 公开演讲名单。Tier 按职级派生(T1 = C 级 / SVP,重点拓展)。
Total leads
leads 总数
32 unique orgs
覆盖 32 家机构
Tier 1
T1
C-suite / SVP
C 级 / 高级副总裁
Tier 2
T2
VP level
副总裁级
Tier 3
T3
Director & below
总监及以下
Pharma
药企
27 orgs
27 家机构
CRO
CRO
5 firms
5 家 CRO
C-suite & SVP safety leaders — AuroraPrime's key targetsC 级与 SVP 安全领导者 — AuroraPrime 重点目标
Tier-1 leads (C-suite / SVP / global heads) — the economic buyers for AI safety-document authoring.
T1 级 leads(C 级 / 高级副总裁 / 全球负责人)——AI 安全文档撰写的经济决策者。
Felix Arellano
SVP, Global Head of Safety and Risk Management
Roche
Mariette Boerstoel
SVP, Worldwide Patient Safety Officer
Bristol Myers Squibb
Juhaeri Juhaeri
VP & Global Head, Epidemiology and Benefit-Risk
Sanofi
Andrea Best
VP and Head of Patient Safety
Gilead Sciences
Karthik Muthusamy
Executive Director, Head of Patient Safety
Novo Nordisk
Gloria Bustos
Global Head, Global Patient Safety
Vantive
Rahul Khajuria
Executive Director, Global Head of Patient Safety Systems and Analytics
United Therapeutics
Joshua Gagne
VP and Global Head of Epidemiology
Janssen Global Services LLC
Tuan Dong Si
SVP, Clinical Safety and Benefit Risk Management
Nuvalent
Gerson Peltz
SVP of Patient Safety & Pharmacovigilance
Arcus Biosciences
Pav Rishiraj
Director, Head of Patient Safety & ABPI PV Expert Chair
Ipsen & ABPI
Priyanka Chhikara
Senior Director, Head of Global Risk Management, Aggregate Reports and PV Data Science
CSL Behring
Most active pharma & CROs among target leads目标 leads 中出场最频繁的药企与 CRO
Click a count to see the related leads; click a name to scroll to its row in the table below.
点击数字可查看相关 leads;点击名称可滚动到下方表格的对应行。
Pharma orgs药企机构
27 orgs · 33 leads27 家 · 33 位- Sanofi
- Bayer
- BMS
- J&J
- Pfizer
- Amgen
- Arcus Biosciences
- AstraZeneca
- Beam Therapeutics
- Chanel
- Compass Pathways
- CSL Behring
- Eli Lilly
- Gilead
- Ipsen
- Kyowa Kirin
- Merz Aesthetics
- Moderna
- Novartis
- Novo Nordisk
- Nuvalent
- Opella
- Roche
- Takeda
- Unilever
- United Therapeutics
- Vantive
CROsCRO
5 · 55 家 · 5 位- JD Pharma
- JSC Farmak
- Parexel
- TLR Therapeutics
- Vitalis
Trending Topics among Pharma & CRO leads药企与 CRO leads 热词趋势
Keywords extracted from each lead's focus area / track. Chip size reflects how many leads map to the topic — hover any chip to see who.
从每位 lead 的关注领域 / 轨道中提取的关键词。芯片大小反映映射到该主题的 leads 数;悬停查看具体人员。
Based on 38 WPSC pharma & CRO leads · chip size = frequency · hover for context基于 WPSC 38 位药企 & CRO leads · 芯片大小 = 频次 · 悬停查看上下文
All target leads全部目标 leads
38 leads, sortable by Tier / company / track. Use search & filters to find target leads; click a row for details and a LinkedIn lookup.
共 38 位 leads,可按优先级 / 公司 / 议题排序。使用搜索与筛选定位目标 lead;点击行查看详情与 LinkedIn 检索。
| # | Tier优先级▲ | Org · Speaker机构 · 演讲人⇅ | When · Where时间 · 地点⇅ | Track议题⇅ | Session场次 | Links链接 |
|---|---|---|---|---|---|---|
| 1 | Tier 1T1 Pharma药企 | Arcus Biosciences Gerson Peltz SVP of Patient Safety & Pharmacovigilance | TBA TBA Oct 14–15, 2026 | Patient Safety | Patient Safety — speaker profile #— | LinkedIn 🔍 |
| 2 | Tier 1T1 Pharma药企 | Bristol Myers Squibb Mariette Boerstoel SVP, Worldwide Patient Safety Officer | TBA TBA Oct 14–15, 2026 | Patient Safety | Patient Safety — speaker profile #— | LinkedIn 🔍 |
| 3 | Tier 1T1 Pharma药企 | CSL Behring Priyanka Chhikara Senior Director, Head of Global Risk Management, Aggregate Reports and PV Data Science | TBA TBA Oct 14–15, 2026 | Safety Risk Management | Safety Risk Management — speaker profile #— | LinkedIn 🔍 |
| 4 | Tier 1T1 Pharma药企 | Gilead Sciences Andrea Best VP and Head of Patient Safety | TBA TBA Oct 14–15, 2026 | Patient Safety | Patient Safety — speaker profile #— | LinkedIn 🔍 |
| 5 | Tier 1T1 Pharma药企 | Ipsen & ABPI Pav Rishiraj Director, Head of Patient Safety & ABPI PV Expert Chair | TBA TBA Oct 14–15, 2026 | Patient Safety | Patient Safety — speaker profile #— | LinkedIn 🔍 |
| 6 | Tier 1T1 Pharma药企 | Janssen Global Services LLC Joshua Gagne VP and Global Head of Epidemiology | TBA TBA Oct 14–15, 2026 | RWE & Data Analytics | RWE & Data Analytics — speaker profile #— | LinkedIn 🔍 |
| 7 | Tier 1T1 Pharma药企 | Novo Nordisk Karthik Muthusamy Executive Director, Head of Patient Safety | TBA TBA Oct 14–15, 2026 | Patient Safety | Patient Safety — speaker profile #— | LinkedIn 🔍 |
| 8 | Tier 1T1 Pharma药企 | Nuvalent Tuan Dong Si SVP, Clinical Safety and Benefit Risk Management | TBA TBA Oct 14–15, 2026 | Safety Risk Management | Safety Risk Management — speaker profile #— | LinkedIn 🔍 |
| 9 | Tier 1T1 Pharma药企 | Roche Felix Arellano SVP, Global Head of Safety and Risk Management | TBA TBA Oct 14–15, 2026 | Safety Risk Management | Safety Risk Management — speaker profile #— | LinkedIn 🔍 |
| 10 | Tier 1T1 Pharma药企 | Sanofi Juhaeri Juhaeri VP & Global Head, Epidemiology and Benefit-Risk | TBA TBA Oct 14–15, 2026 | Safety Risk Management | Safety Risk Management — speaker profile #— | LinkedIn 🔍 |
| 11 | Tier 1T1 Pharma药企 | United Therapeutics Rahul Khajuria Executive Director, Global Head of Patient Safety Systems and Analytics | TBA TBA Oct 14–15, 2026 | RWE & Data Analytics | RWE & Data Analytics — speaker profile #— | LinkedIn 🔍 |
| 12 | Tier 1T1 Pharma药企 | Vantive Gloria Bustos Global Head, Global Patient Safety | TBA TBA Oct 14–15, 2026 | Patient Safety | Patient Safety — speaker profile #— | LinkedIn 🔍 |
| 13 | Tier 2T2 Pharma药企 | Compass Pathways William Haddock VP of Clinical Safety and Pharmacovigilance | TBA TBA Oct 14–15, 2026 | Patient Safety | Patient Safety — speaker profile #— | LinkedIn 🔍 |
| 14 | Tier 2T2 Pharma药企 | Johnson & Johnson Julie Thomas VP, Global Medical Safety Operations | TBA TBA Oct 14–15, 2026 | Global PV | Global PV — speaker profile #— | LinkedIn 🔍 |
| 15 | Tier 2T2 Pharma药企 | Merz Aesthetics Juan Daccach VP, Global Product Safety | TBA TBA Oct 14–15, 2026 | Patient Safety | Patient Safety — speaker profile #— | LinkedIn 🔍 |
| 16 | Tier 2T2 Pharma药企 | Pfizer Reema Mehta VP, Head of Risk Assessment and Management | TBA TBA Oct 14–15, 2026 | Safety Risk Management | Safety Risk Management — speaker profile #— | LinkedIn 🔍 |
| 17 | Tier 3T3 Pharma药企 | Amgen Siva Kumar Buddha Medical Director, Global Patient Safety | TBA TBA Oct 14–15, 2026 | Patient Safety | Patient Safety — speaker profile #— | LinkedIn 🔍 |
| 18 | Tier 3T3 Pharma药企 | AstraZeneca E. Alton Sartor Medical Director, Safety Digital and Devices | TBA TBA Oct 14–15, 2026 | Next Gen Tech & Data | Next Gen Tech & Data — speaker profile #— | LinkedIn 🔍 |
| 19 | Tier 3T3 Pharma药企 | Bayer Hinna Shahid Global Medical Director | TBA TBA Oct 14–15, 2026 | Patient Safety | Patient Safety — speaker profile #— | LinkedIn 🔍 |
| 20 | Tier 3T3 Pharma药企 | Bayer Sudheer Reddy Head BRM CoE | TBA TBA Oct 14–15, 2026 | Safety Risk Management | Safety Risk Management — speaker profile #— | LinkedIn 🔍 |
| 21 | Tier 3T3 Pharma药企 | Beam Therapeutics Ankit Lodaya Senior Director Pharmacovigilance | TBA TBA Oct 14–15, 2026 | Patient Safety | Patient Safety — speaker profile #— | LinkedIn 🔍 |
| 22 | Tier 3T3 Pharma药企 | Bristol Myers Squibb Subhayan Das Director BI&T, Data & Analytics — Patient Safety | TBA TBA Oct 14–15, 2026 | RWE & Data Analytics | RWE & Data Analytics — speaker profile #— | LinkedIn 🔍 |
| 23 | Tier 3T3 Pharma药企 | Chanel Tasia-Leigh Deleon Manager, Cosmetovigilance | TBA TBA Oct 14–15, 2026 | Patient Centricity | Patient Centricity — speaker profile #— | LinkedIn 🔍 |
| 24 | Tier 3T3 Pharma药企 | Eli Lilly and Company Rohan Nanda Executive Medical Director & Early Phase Drug Physician | TBA TBA Oct 14–15, 2026 | Patient Safety | Patient Safety — speaker profile #— | LinkedIn 🔍 |
| 25 | Tier 3T3 Pharma药企 | Kyowa Kirin Tanmay Desai Head, Global PV Operations | TBA TBA Oct 14–15, 2026 | Global PV | Global PV — speaker profile #— | LinkedIn 🔍 |
| 26 | Tier 3T3 Pharma药企 | Moderna Therapeutics Ella Nnadili-Okonkwo Sr. Medical Director, Global Clinical Safety Lead, Therapeutics & Oncology | TBA TBA Oct 14–15, 2026 | Patient Safety | Patient Safety — speaker profile #— | LinkedIn 🔍 |
| 27 | Tier 3T3 Pharma药企 | Novartis Pharmaceuticals Corporation Tony Nguyen Head of US Patient Safety & Pharmacovigilance | TBA TBA Oct 14–15, 2026 | Patient Safety | Patient Safety — speaker profile #— | LinkedIn 🔍 |
| 28 | Tier 3T3 Pharma药企 | Opella Santosh Srirangam PV Systems & Data Strategy Head | TBA TBA Oct 14–15, 2026 | RWE & Data Analytics | RWE & Data Analytics — speaker profile #— | LinkedIn 🔍 |
| 29 | Tier 3T3 Pharma药企 | Pfizer Sharon Reid Director Risk Management Product Lead | TBA TBA Oct 14–15, 2026 | Safety Risk Management | Safety Risk Management — speaker profile #— | LinkedIn 🔍 |
| 30 | Tier 3T3 Pharma药企 | Sanofi Anil Mor Head of Epidemiology, Analytics & Innovation | TBA TBA Oct 14–15, 2026 | RWE & Data Analytics | RWE & Data Analytics — speaker profile #— | LinkedIn 🔍 |
| 31 | Tier 3T3 Pharma药企 | Sanofi William Blumentals Head of Pharmacoepidemiology, Specialty Care | TBA TBA Oct 14–15, 2026 | RWE & Data Analytics | RWE & Data Analytics — speaker profile #— | LinkedIn 🔍 |
| 32 | Tier 3T3 Pharma药企 | Takeda Shefali Jobanputra CPASS Compliance, Process and Training Lead | TBA TBA Oct 14–15, 2026 | Patient Safety | Patient Safety — speaker profile #— | LinkedIn 🔍 |
| 33 | Tier 3T3 Pharma药企 | Unilever Viny Srinivasan Head, Global Market Vigilance, Beauty & Wellbeing | TBA TBA Oct 14–15, 2026 | Patient Centricity | Patient Centricity — speaker profile #— | LinkedIn 🔍 |
| 34 | CROCRO CROCRO | JD Pharma Services Joan D'souza Local QPPV | TBA TBA Oct 14–15, 2026 | Patient Safety | Patient Safety — speaker profile #— | LinkedIn 🔍 |
| 35 | CROCRO CROCRO | JSC Farmak Galyna Cordero Head of Pharmacovigilance Department, QPPV | TBA TBA Oct 14–15, 2026 | Patient Safety | Patient Safety — speaker profile #— | LinkedIn 🔍 |
| 36 | CROCRO CROCRO | Parexel Sanjay Vyas President, Safety & Logistics and Country Head of India | TBA TBA Oct 14–15, 2026 | Patient Safety | Patient Safety — speaker profile #— | LinkedIn 🔍 |
| 37 | CROCRO CROCRO | TLR Therapeutics Israel Gutierrez Chief Medical Officer | TBA TBA Oct 14–15, 2026 | Patient Safety | Patient Safety — speaker profile #— | LinkedIn 🔍 |
| 38 | CROCRO CROCRO | Vitalis Adriana Aristizabal Medical Director | TBA TBA Oct 14–15, 2026 | Patient Safety | Patient Safety — speaker profile #— | LinkedIn 🔍 |
Click any row to open full session details. Tier badge reflects sales-team priority. LinkedIn links are auto-discovered (Firecrawl) — verify before outreach.点击任意行查看完整场次信息。Tier 徽章表示销售团队的优先级;LinkedIn 链接为自动抓取(Firecrawl),外联前请人工核对。
Source: WPSC Americas 2026 public speaker roster (terrapinn.com). No sales Excel exists for this conference, so leads are speaker-derived: tiers are derived from job seniority (not a sales-assigned priority), headshots are unavailable (initials shown), and LinkedIn URLs are not pre-resolved (a LinkedIn search link is provided per lead). Verify before outreach.数据来源:WPSC 美洲 2026 公开演讲名单(terrapinn.com)。本会议无销售 Excel,故 leads 由演讲名单派生:tier 按职级推导(非销售标注的优先级),无头像(显示首字母),LinkedIn 未预先解析(每位提供 LinkedIn 检索链接)。外联前请核对。
